Oncology RCM Software

RCM in a Oncology Practice

The revenue cycle in medical oncology turns on drugs. The practice buys chemotherapy, immunotherapy and supportive drugs, gives them in its own infusion suite, and bills each one by HCPCS code and units. Medicare Part B pays most of these drugs from quarterly ASP files, and commercial plans pay by contract. Every step has to hold up. Coverage and approvals are confirmed before the drug is mixed. The nurse's record becomes drug, waste and administration lines. Claims are scrubbed for units, NDCs and coverage rules before they go out. Remittances post line by line, and drug payments are compared with the price the practice paid. Denials are worked in order of dollars and filing limits. Oncology RCM software ties these steps to one record and one set of reports, so the practice can see where money is lost: at the front desk, in the chair, on the claim or in follow-up. That view matters whether billing staff are in-house or outside.

Why Is RCM Different in Oncology?

In most specialties, the revenue cycle protects professional fees. In a community oncology practice, it also protects the practice's largest cost. Drugs are bought weeks before they are paid for, and a single denied immunotherapy claim can wipe out the margin on many visits. A revenue cycle built for office visits doesn't watch drug cost, drug payment and drug waste closely enough.

Payment rules for those drugs change often. Medicare drug payment limits update every quarter, new biosimilars get their own Q-codes, and some Part B drugs carry reduced coinsurance in some quarters under the inflation rebate program. Commercial plans add their own preferred products and approval rules. RCM for oncology has to keep current fee data and policy rules in the system, not in a binder.

Value-based programs add a second track. Practices in the Enhancing Oncology Model receive monthly payments for enhanced services and are measured on total cost of care for six-month episodes. The same revenue cycle that bills fee-for-service drugs must track model payments and the cost of each episode, so leaders can see how both tracks are doing.

What Oncology RCM Software Handles

Quarterly ASP drug payment limits

CMS posts Medicare Part B drug payment limit files each quarter, along with NDC-to-HCPCS crosswalks. Fee schedules are loaded each quarter, so expected payment and drug margin reflect current rates under ASP-based pricing. (CMS: Medicare Part B Drug Payment Limit (ASP) Pricing Files and NDC-HCPCS crosswalks)

Biosimilar payment and Q-codes

Each biosimilar has its own HCPCS code, such as Q5107, Q5118, Q5126 and Q5129 for bevacizumab products, while the reference drug bills as J9035. Charges and fee data are kept per code, so margin on a biosimilar is not mixed with its reference product. (CMS Medicare Coverage Database, Billing and Coding Article A52370: Bevacizumab and biosimilars)

JW and JZ modifiers on single-dose drugs

For Medicare Part B, discarded drug from a single-dose container is billed on a separate JW line, and JZ attests that nothing was discarded. Waste lines are built from the documented dose and vial size, so waste is billed and reported correctly. (CMS: Discarded Drugs and Biologicals, JW and JZ modifier policy)

Medically Unlikely Edits on drug units

An MUE sets the most units of a code that a provider would report for one patient on one date of service. Drug units are checked against MUEs before submission, so a high-dose claim is reviewed rather than auto-denied. (CMS: Medicare NCCI Medically Unlikely Edits (MUEs))

Enhancing Oncology Model payments

EOM pays participants a monthly enhanced services payment per attributed patient, with a higher amount for dually eligible patients, and measures cost across six-month episodes. Model payments are tracked apart from fee-for-service collections in RCM reports. (CMS Innovation Center: Enhancing Oncology Model (EOM))

How Does Oncology RCM Software Work?

1. 1. Clear the patient and regimen

   Eligibility, drug benefits and approvals are confirmed before the first cycle. The oncology financial clearance team works one queue by drug and plan.

2. 2. Capture every drug and service

   The infusion record becomes drug, waste, administration and visit lines. Oncology charge validation checks units, modifiers and edits before billing.

3. 3. Submit and track claims

   Clean claims go out electronically and are tracked through acknowledgment and status. Oncology medical billing handles secondary claims to supplements and Medicaid.

4. 4. Post and compare payments

   ERAs post line by line. Drug payments are compared with expected rates and the practice's purchase price.

5. 5. Work denials and measure results

   Denials are sorted by value and filing limit and worked by cause. KPIs show drug claim denials, AR days and drug margin by payer.

Oncology RCM Software vs. Generic Software

Who Uses It in a Oncology Practice

• Revenue cycle director: One view from approvals to payment, with drug claim denials and AR by payer in the same reports.
• Practice owner: Drug margin by product and payer, and a clear read on whether billing should stay in-house or move out.
• Billing manager: Work queues for clearance gaps, charge edits and oncology denial management, sorted by what is at risk.